Recent Presentations by Michael Lagios, MD

5/29/12–5/30/12. Sioux Falls, South Dakota.
  • DCIS update
4/15/12–4/18/12. The Breast Course. Lisbon, Portugal.
  • Core and open biopsy pathology: Tissue processing and problems with concordance
  • High Risk lesions
  • DCIS management update
  • Lymph node pathological assessment, staging and prognostic factors
3/9/12–3/11/12. Practical Breast MRI. Atlanta, Georgia.
  • Factors Impacting Concordance
  • Lymph Node Pathology
2/8/12–2/10/12. Patologia Mamaria. Eolegio Mexicano de Especialistas en Ginecologia y Obstetricia. Mexico City, Mexico.
  • Problems in Tumor Sizing
  • Factors Impacting Concordance in Breast Pathology
  • DCIS, A Gordian Knot Untied
4/3/11–4/6/11. The Breast Course. Istanbul, Turkey.
  • High-risk Pathologies
  • DCIS Pathology
  • Is Radio-therapy Sufficient for Margin Control?
  • Invasive Cancer Pathology and Staging
  • Lymph Node Pathological Assessment and Prognostic Factors
3/25–3/26/11. American Society of Breast Disease 35th Annual Symposium. Dallas, Texas.
  • DCIS: A Fortuitous Odyssey. Where We Were and How We Got Here
3/4–3/6/11. Practical Breast Imaging, Intervention and Innovations. Institute for Advanced Medical Education. Miami Beach, Florida.
  • Management of High Risk Lesions in Image-guided Core Biopsy: The Case for Conservative Follow-up in Selected Cases
  • Prognostic Factors for Invasive Cancers
Breast Pathology Photomicrograph by Michael Lagios, MD
2/26–2/27/11. Practical Breast MRI: Applications & Interventions for Clinical Practice. Institute for Advanced Medical Education. Las Vegas, Nevada.
  • Factors Impacting Concordance in Breast Pathology: Core Biopsy and Resections
  • Can Breast Conservation be Successful Absent Radiation Therapy: DCIS and Invasive Carcinoma
3/26–3/28/10. Practical Breast MRI: Applications and Interventions for Clinical Practice. Institute for Advanced Medical Education. Atlanta, Georgia.
  • Factors Impacting Concordance in Breast Biopsy: Review of Technical and Diagnostic Problems in Core Biopsy
  • Problems in Tumor Sizing and their Impact on Prognostic Projections and Therapeutic Decisions
  • New CAP Guideline for Reporting DCIS
3/20–3/24/10. 20th Annual National Interdisciplinary Breast Center Conference. National Consortium of Breast Centers. Las Vegas, Nevada
  • The Impact of Diagnostic Discordance and False Economies in Pathology Practice on Patient Care
  • Management of High Risk and Atypical Lesions in Percutaneous Image-guided Core Biopsy of the Breast
3/12–3/14/10. BI 3 2010. Breast Imaging Intervention and Innovations. Las Vegas, Nevada.
  • New CAP Guidelines for Reporting of DCIS and Likely Impact
  • Problems in Tumor Sizing and Their Impact on Prognostic Projections and Therapeutic Decisions
  • Factors Impacting Concordance in Breast Biopsy. Review of Technical and Diagnostic Problems in Core Biopsy and Large Resections
2/21–2/24/10. The Breast Course. Phoenix, Arizona.
  • Radiologic/Pathologic Management of DCIS
  • Radiologic/Pathologic Management of Concordant/Discordant Lesions
  • High-Risk Biopsy Findings
  • Lymph Node Pathologic Assessment
  • Management of High Risk Lesions
  • Duct Carcinoma In Situ Pathology
2/11/10. Grand Rounds, St. Mary’s Medical Center. San Francisco, CA.
  • Benefits of Sentinel Lymph Node Biopsy
10/24–10/27/09. The 15th Annual Multidisciplinary Symposium on Breast Disease & The First International Breast Health Educational Program. Cairo, EGYPT.
  • The Impact of Pathologic and Mammographic Correlation in Patient Care
  • Do All DCIS Patients Require Radiation Therapy and Tamoxifen?
  • Difficult To Diagnose Cases in Breast Pathology
6/10–6/13/09. Consensus Conference III: Image-Detected Breast Cancer: State-of-the-Art Diagnosis and Treatment 2009. Newport Beach, California.
  • CAP Guidelines (2009) for DCIS Tissue Processing. Statement Drafting Committee
Breast Pathology Photomicrograph by Michael Lagios, MD
4/26–4/29/09. The Breast Course. 2009 Edition. Nice, FRANCE.
  • Lymph Node Pathological Assessment
  • Pathologic Prognostic Factors
  • High-risk Biopsy Findings
  • Radiologic/Pathologic Management of Concordant/Discordant Lesions
  • Radioilogic/Pathologic Management of High Risk Lesions
  • DCIS Pathology
  • Radiologic/Pathologic Management of DCIS Debate:
  • Contralateral Breast Cancer Risk
2/6–2/8/09. 5th Annual Breast Imaging Intervention and Innovations. Atlanta, Georgia.
  • DCIS and High Risk Lesions
  • Panel: Staging
4/13–4/16/08. The Breast Course. Quebec City, Canada.
  • Pathologic Factors Entering Prognostic Indexes
  • High Risk Biopsy Findings
  • Radiology/Pathology Management of Concordant Benign and Malignant Lesions
  • The Truth About DCIS
  • Lymph Node Pathological Assessment
  • Radiation Therapy in DCIS, Debate
4/10–4/12/08. 32nd Annual Symposium, American Society of Breast Disease. San Diego, CA.
  • Surgical Management of Early Breast Cancer Debate
3/7–3/8/08. Practical Breast MRI: Intervention for Clinical Practice. Atlanta, GA.
  • Impact of Technical Variables on Diagnostic Yield: Core Biopsy and Resection Procedures
  • Significance and Management of High-risk and Atypical Lesions in Percutaneous Core Biopsies
10/7/07. 93rd Annual Clinical Congress of the American College of Surgeons. New Orleans, LA.
  • Ductal carcinoma in situ: evolving strategies for optimal diagnosis and management
4/13/07. Multidisciplinary Breast Cancer Symposium, Kaiser Permanente. Dana Point, California.
  • Problems in Determination of Tumor Size and Margins for T1 Invasive Carcinomas and Ductal Carcinoma in Situ and Their Impact on Treatment and Outcome
3/12–3/15/07. The Breast Course. Key Largo, Florida.
  • Breast Pathology, Tumor Sizing
  • High-risk Biopsy Findings
  • Radiological/Pathological Correlations: Re-biopsy vs. Follow-up
  • Prognostic Factors for DCIS
  • What is a Significant Metastasis? What is its Size, How is it Identified, What is Valid
  • Breast Pathology Basics for Non-Pathologists
3/2–3/4/07. Practical Breast MRI: Applications and Interventions for Clinical Practice. Lake Buena Vista, Florida.
  • Benign Proliferative Change Versus DCIS
2/17–2/19/07. University of Arkansas Department of Surgery Breast Cancer Challenge. Ridgedale, Missouri.
  • How to Identify Favorable Subsets of DCIS for which Radiation Therapy and Tamoxifen Provide No Significant Benefit
2/1–2/2/07. National Institutes of Health. National Cancer Institute. Strategies for Integrating Tumor Biology and Population Sciences. DCIS Workshop. San Francisco, CA.
  • Impact of Pathology Practice on Outcome in Published Studies of DCIS and Recommendations for a Uniform Pathology Protocol
10/25–10/29/06. Chicago International Breast Course. Chicago, Illinois.
  • Significance and Management of High-risk Lesions in Image-guided Percutaneous Specimens
  • Problems in Staging: Tumor Size and Sentinel Lymph Node Procedures
  • DCIS: Can We Identify Subsets Who Can be Spared Irradiation?
Breast Pathology Photomicrograph by Michael Lagios, MD
8/3–8/6/06. 24th Annual Pittsburgh Breast Imaging Seminar. Pittsburgh, Pennsylvania.
  • Ductal Carcinoma In Situ: The Pathologist’s Approach
  • High-Risk Lesions in Minimally Invasive Breast Biopsy Specimens
  • Tumor Sizing: Is the Radiologist Creating a Dilemma with Large Core Biopsies?
7/25–7/29/06. Bayreuth International Breast Cancer Symposium. Bayreuth, Germany.
  • DCIS: Update of the Lagios and Van Nuys Experience
  • Pitfalls of DCIS Diagnosis and its Clinical Significance
3/13–3/18/06. The Breast Course, 2006. Key Largo, Florida.
  • Breast Pathology Update
  • Interpretation of Core Biopsy Material–Maximizing Yield and Avoiding Error
  • Radiological-pathological Correlation after Minimally Invasive Breast Biopsy: When is Biopsy vs. Follow-up Recommended?
  • Variables Impacting Upgrades of ADH to DCIS
  • Invasion Following Open Biopsy
3/12/06. 16th Annual National Interdisciplinary Breast Center Conference. Las Vegas, NV.
  • High Risk Women: Pathologic Features of Precursors and Breast Cancer
2/11/06. Breast Imaging, Intervention and Innovations. IAME. Atlanta, Georgia.
  • Maximizing Diagnostic Yield from Image-Guided Percutaneous Biopsies and Determination of Tumor Size
  • Management of High-Risk Lesions in Image-guided Percutaneous Biopsies
  • How to Interpret a SLN Biopsy: What is a Metastasis and What Is Not
  • DCIS–Where Are We–Some Recommendations

↑ Return to top